PIEKOS BRIAN (Chief Financial Officer) reported 1 transaction at KALVISTA PHARMACEUTICALS, INC.
Review the transaction codes below to understand the nature of each event.
Filed: 6/11/2026ACC: 0001815308-26-000006
Officer· Chief Financial Officer
Since Feb 2026
-270.41K
Net shares
Net seller
$0.00
Total acquired
0
Open market trades
0B · 0S
4
Total transactions
270.41K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−21.66K
Price / share
—
Trade value
—
% of position
New position
6/11/2026
21.66K→0.00
Total
Net shares
−21.66K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 6/11/2026 | D · Disposition | −21.66K | — | — | New position | 21.66K | 0.00 |
| Total | −21.66K | $0.00 | ||||||
Derivative Transactions3
Stock Option (Right to Buy)
Direct
Converts to
Common Stock
100K shares
Shares
−100K
Strike price
11.87
Held after
0.00
Exercisable
—
6/11/2026
Restricted Stock Unit
Direct
Converts to
Common Stock
55K shares
Shares
−55K
Strike price
Held after
0.00
Exercisable
—
6/11/2026
Restricted Stock Unit
Direct
Converts to
Common Stock
93.75K shares
Shares
−93.75K
Strike price
Held after
0.00
Exercisable
—
6/11/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Stock100K shares | 6/11/2026 | D · Disposition | −100K | 11.87 | — | 0.00 |
| Restricted Stock Unit Direct | Common Stock55K shares | 6/11/2026 | D · Disposition | −55K | — | 0.00 | |
| Restricted Stock Unit Direct | Common Stock93.75K shares | 6/11/2026 | D · Disposition | −93.75K | — | 0.00 |